Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

946 ARTÍCULOS , VIENDO DEL 286 AL 300

Focal dystonia in a case of SYNE1 spastic-ataxia: Expanding the phenotypic spectrum

Holla VV, Surisetti BK, Prasad S, Pal PK.

Parkinsonism Relat Disord. 2021 Jun;87:22-24. doi: 10.1016/j.parkreldis.2021.04.014. Epub 2021 Apr 25.

Neurological Manifestations of COVID-19 Associated Multi-system Inflammatory Syndrome in Children: A Systematic Review and Meta-analysis

Nepal G, Shrestha GS, Rehrig JH, Gajurel BP, Ojha R, Agrawal A, Panthi S, Khatri B, Adhikari I.

J Nepal Health Res Counc. 2021 Apr 23;19(1):10-18. doi: 10.33314/jnhrc.v19i1.3410.

Closed spinal dysraphism in a 6-month-old mixed breed dog

Franco GG, de Siqueira EGM, de Souza JAL, de Castro PLO, Rahal SC, Mamprim MJ, Minto BW, Brandao CVS, Junior JSC.

Vet Med (Praha). 2021 May 3;66(5):219-224. doi: 10.17221/68/2020-VETMED. eCollection 2021 May.

Wernicke Encephalopathy in an Elderly Patient Due to Chronic Malnutrition From an Atypical Diet

Shah FA, Moronta S, Braford M, Fujikawa PY, Stocker G.

Cureus. 2021 Mar 31;13(3):e14210. doi: 10.7759/cureus.14210.

A novel de novo intronic variant in ITPR1 causes Gillespie syndrome

Keehan L, Jiang MM, Li X, Marom R, Dai H, Murdock D, Liu P, Hunter JV, Heaney JD, Robak L, Emrick L, Lotze T, Blieden LS; Undiagnosed Diseases Network; Lewis RA, Levin AV, Capasso J, Craigen WJ, Rosenfeld JA, Lee B, Burrage LC.

Am J Med Genet A. 2021 Aug;185(8):2315-2324. doi: 10.1002/ajmg.a.62232. Epub 2021 May 5.

Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort

Rummey C, Flynn JM, Corben LA, Delatycki MB, Wilmot G, Subramony SH, Bushara K, Duquette A, Gomez CM, Hoyle JC, Roxburgh R, Seeberger L, Yoon G, Mathews KD, Zesiewicz T, Perlman S, Lynch DR.

Ann Clin Transl Neurol. 2021 Jun;8(6):1239-1250. doi: 10.1002/acn3.51352. Epub 2021 May 5.

Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia

Benussi A, Cantoni V, Manes M, Libri I, Dell'Era V, Datta A, Thomas C, Ferrari C, Di Fonzo A, Fancellu R, Grassi M, Brusco A, Alberici A, Borroni B.

Brain. 2021 Sep 4;144(8):2310-2321. doi: 10.1093/brain/awab157.

EBF3 Neurodevelopmental Disorder

Narayanan DL, Kutsche K, Girisha KM.

2021 May 6. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Progressive cerebellar atrophy in a patient with complex II and III deficiency and a novel deleterious variant in SDHA: A Counseling Conundrum

Sturrock BRH, Macnamara EF, McGuire P, Kruk S, Yang I, Murphy J; Undiagnosed Diseases Network; Tifft CJ, Gordon-Lipkin E.

Mol Genet Genomic Med. 2021 Jun;9(6):e1692. doi: 10.1002/mgg3.1692. Epub 2021 May 7.

Spinocerebellar ataxia type 2 from an evolutionary perspective: Systematic review and meta-analysis

Sena LS, Dos Santos Pinheiro J, Hasan A, Saraiva-Pereira ML, Jardim LB.

Clin Genet. 2021 Sep;100(3):258-267. doi: 10.1111/cge.13978. Epub 2021 May 27.

Evaluation of Pexion(®) (imepitoin) for treatment of storm anxiety in dogs: A randomised, double-blind, placebo-controlled trial

Perdew I, Emke C, Johnson B, Dixit V, Song Y, Griffith EH, Watson P, Gruen ME.

Vet Rec. 2021 May;188(9):e18. doi: 10.1002/vetr.18. Epub 2021 Jan 21.

X-Linked Parkinsonism: Phenotypic and Genetic Heterogeneity

Di Lazzaro G, Magrinelli F, Estevez-Fraga C, Valente EM, Pisani A, Bhatia KP.

Mov Disord. 2021 Jul;36(7):1511-1525. doi: 10.1002/mds.28565. Epub 2021 May 7.

Recent developments of HDAC inhibitors: Emerging indications and novel molecules

Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schiöth HB.

Br J Clin Pharmacol. 2021 Dec;87(12):4577-4597. doi: 10.1111/bcp.14889. Epub 2021 May 27.

Case of cerebellar ataxia successfully treated by virtual reality-guided rehabilitation

Takimoto K, Omon K, Murakawa Y, Ishikawa H.

BMJ Case Rep. 2021 May 10;14(5):e242287. doi: 10.1136/bcr-2021-242287.

Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer

Kim ST, Smith SA, Mortimer P, Loembé AB, Cho H, Kim KM, Smith C, Willis S, Irurzun-Arana I, Berges A, Hong JY, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kozarewa I, Pierce AJ, Dean E, Lee J.

Clin Cancer Res. 2021 Sep 1;27(17):4700-4709. doi: 10.1158/1078-0432.CCR-21-0251. Epub 2021 May 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias